ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,615, issued on April 21, was assigned to KYOWA KIRIN Co. LTD. (Tokyo). "Anti-FGF23 antibody or antibody fragment thereof" was invented by ... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,616, issued on April 21, was assigned to Cardiff Oncology Inc. (San Diego). "PLK1 inhibitor in combination with anti-angiogenics for treat... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,617, issued on April 21, was assigned to Kings's College London (London). "Composition comprising an IgE antibody" was invented by James S... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,618, issued on April 21, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.). "Antagonist anti-NPR1 antibodies and methods of... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,619, issued on April 21, was assigned to HUAHUI HEALTH LTD. (Beijing). "Human monoclonal antibodies against TIGIT for immune related disea... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,620, issued on April 21, was assigned to LG CHEM Ltd. (Seoul, South Korea). "Anti-LILRB1 antibody and uses thereof" was invented by Yoon A... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,621, issued on April 21, was assigned to PRECISION BIOLOGICS INC. (Bethesda, Md.). "Humanized monoclonal antibodies and methods of use for... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,622, issued on April 21, was assigned to AB Studio Inc. (Hayward, Calif.). "Heteromultimeric proteins and methods of use thereof" was inve... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,623, issued on April 21, was assigned to ALLOGENE THERAPEUTICS INC. (South San Francisco, Calif.) and PFIZER INC. (New York). "DLL3 target... Read More
ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,624, issued on April 21, was assigned to NovoMab BioPharmaceuticals Inc (Nanjing, China). "Antibody that specifically binds to human CTLA4... Read More